A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. - refine.bio

GSE36110

Homo sapiens

18 Downloadable Samples

Technology Badge Icon

Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Submitter Supplied Information

Description

To determine the differential expression of KRAS-variant HNSCC (head and neck squamous cell carcinoma) cell lines.

PubMed ID

Publication Title

A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Total Samples

19

Submitter’s Institution

Johns Hopkins University

Authors

Chung CH, Lee JW, Slebos RJ, Howard JD, Perez J, Kang H, Fertig EJ, Considine M, Gilbert J, Murphy BA, Nallur S, Paranjape T, Jordan RC, Garcia J, Burtness B, Forastiere AA, Weidhaas JB

Source Repository

Gene Expression Omnibus (GEO)

No rows found

Loading...